drugset / Trial / NCT02998190
First-in-Human Single and Multiple Dose of EB8018
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety profile of single and multiple doses of EB8018 in healthy male subjects, to determine the pharmacokinetic profile of single and multiple doses of EB8018 in healthy male subjects and to assess preliminary effects of EB8018 on the healthy male gut microbiome.
Timeline
- Start
- 2016-11
- Primary completion
- 2017-04
- Completion
- 2017-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sibofimloc | Small molecule | — | Oral |
Indications
No indication recorded.